COST-EFFECTIVENESS OF INSULIN DETEMIR IN T2DM PATIENTS POORLY CONTROLLED WITH NPH INSULIN IN POLAND

被引：0
|
作者：
Kaczor, M. P. [1 ]
Pawlik, D. [2 ]
Wojcik, R. [2 ]
Jurkiewicz, B. [3 ]
机构：
[1] Jagiellonian Univ, Coll Med, Krakow, Poland
[2] Aestimo Sc, Krakow, Poland
[3] Novo Nordisk Pharma, Warsaw, Poland
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.682
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A442 / A442
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China
    James L. Palmer
    Meaghan Gibbs
    Huib WKFH Scheijbeler
    Robert W. Kotchie
    Steffen Nielsen
    Jeremy White
    William J. Valentine
    [J]. Advances in Therapy, 2008, 25 : 752 - 774
  • [32] An analysis of the cost-effectiveness of starting insulin detemir in insulin-naive people with type 2 diabetes
    Home, Philip
    Baik, Sei Hyun
    Gonzalez Galvez, Guillermo
    Malek, Rachid
    Nikolajsen, Annie
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (03) : 230 - 240
  • [33] The cost-effectiveness of insulin glulisine in type 2 diabetes in Poland
    Walczak, J.
    Dardzinski, W.
    Kusy, M.
    Lis, J.
    Nogas, G.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A226 - A226
  • [34] COST-EFFECTIVENESS OF INSULIN GLARGINE PLUS ORAL ANTIDIABETIC DRUGS (OADS) COMPARED TO PREMIXED INSULIN FOR TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS IN THE CANADIAN PAYER SETTING
    Minshall, M. E.
    Sauriol, L.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A502 - A502
  • [35] CLINICAL AND COST OUTCOMES OF TREATMENT WITH INSULIN GLARGINE VERSUS INSULIN DETEMIR IN INSULIN NAIVE TYPE 2 DIABETES PATIENTS: COST-EFFECTIVENESS ANALYSIS IN THE KAZAKHSTAN SETTING
    Kostyuk, A.
    Akanov, A.
    Almadiyeva, A.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A203 - A204
  • [36] Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 2 diabetes in the UK
    McEwan, Phil
    Poole, Chris D.
    Tetlow, Tony
    Holmes, Paul
    Currie, Craig J.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S21 - S31
  • [37] COST-EFFECTIVENESS ANALYSIS FOR SOLIQUA IN THE TREATMENT OF T2DM IN TURKIYE
    Atikeler, K.
    Kurnaz, M.
    Ileri, S.
    Cansever, M.
    Kahveci, S.
    Kader, B.
    Duran, C.
    Akbay, E. E.
    Karacar, G.
    Ozturk, F.
    Okcun, S.
    Kockaya, G.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S112 - S112
  • [38] Cost-Effectiveness of Switching to Biphasic Insulin Aspart 30 from Human Insulin in Patients with Poorly Controlled Type 2 Diabetes in South Korea
    Lee, Kyoung Hee
    Seo, Se Jin
    Smith-Palmer, Jayne
    Palmer, James L.
    White, Jeremy
    Valentine, William J.
    [J]. VALUE IN HEALTH, 2009, 12 : S55 - S61
  • [39] Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes
    Philis-Tsimikas, Athena
    Charpentier, Guillaume
    Clauson, Per
    Ravn, Gabriela Martinez
    Roberts, Victor Lawrence
    Thorsteinsson, Birger
    [J]. CLINICAL THERAPEUTICS, 2006, 28 (10) : 1569 - 1581
  • [40] A Comparison of CV-FBG in T2DM with Use of Glargine/NPH as a Basal Insulin
    Mu Pan-Wei
    Zeng Long-Yi
    Zhang Guo-Chao
    Chen Yan-Ming
    Fu Jing-Yi
    Wang Man-Man
    [J]. DIABETES, 2010, 59 : A174 - A174
12345